Daniela-carmen Ababei

Iasi, IS 700115, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Acute Toxicity of Three Synthetic Cannabinoids: First In Vivo Preclinical Study.

Acute Toxicity of Three Synthetic Cannabinoids: First In Vivo Preclinical Study.

Journal: Molecules (Basel, Switzerland)

Published: May 21, 2026

Therapeutic relevance of an EU-GMP certified Cannabis sativa L. strain in a dual in vivo model of cognitive impairment and chronic neuropathic pain.

Therapeutic relevance of an EU-GMP certified Cannabis sativa L. strain in a dual in vivo model of cognitive impairment and chronic neuropathic pain.

Journal: Frontiers in pharmacology

Published: December 05, 2025

Evaluation of long-term safety profile of an EU-GMP certified Cannabis sativa L. strain in a naturally aging preclinical model.

Evaluation of long-term safety profile of an EU-GMP certified Cannabis sativa L. strain in a naturally aging preclinical model.

Journal: Frontiers in pharmacology

Published: October 03, 2025

Multifaced roles of cannabinoid therapy in cancer: balancing analgesia, antitumor potential, and systemic toxicity.

Multifaced roles of cannabinoid therapy in cancer: balancing analgesia, antitumor potential, and systemic toxicity.

Journal: Frontiers in pharmacology

Published: August 24, 2025

The Neuroprotective Potential of Ocimum Plant Species: Seasoning the Mind with Sweet and Holy Basil.

The Neuroprotective Potential of Ocimum Plant Species: Seasoning the Mind with Sweet and Holy Basil.

Journal: Nutrients

Published: August 14, 2025

Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging.

Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging.

Journal: Journal of cannabis research

Published: November 08, 2024

JWH-182: a safe and effective synthetic cannabinoid for chemotherapy-induced neuropathic pain in preclinical models.

JWH-182: a safe and effective synthetic cannabinoid for chemotherapy-induced neuropathic pain in preclinical models.

Journal: Scientific reports

Published: April 22, 2024

Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer's Disease Treatment.

Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer's Disease Treatment.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 20, 2024

Inflammasome Molecular Insights in Autoimmune Diseases.

Inflammasome Molecular Insights in Autoimmune Diseases.

Journal: Current issues in molecular biology

Published: March 18, 2024

Therapeutic Implications of Renin-Angiotensin System Modulators in Alzheimer's Dementia.

Therapeutic Implications of Renin-Angiotensin System Modulators in Alzheimer's Dementia.

Journal: Pharmaceutics

Published: August 10, 2023

The Impact of Some Modulators of the Renin-Angiotensin System on the Scopolamine-Induced Memory Loss Mice Model.

The Impact of Some Modulators of the Renin-Angiotensin System on the Scopolamine-Induced Memory Loss Mice Model.

Journal: Brain sciences

Published: July 10, 2023

Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity.

Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity.

Journal: Biomedicines

Published: April 18, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026